We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SENEB:NASDAQSeneca Foods Corp. Analysis

Data as of 2026-09-01 - not real-time

$193.67

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Seneca Foods Corporation trades at $193.67, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 13.1%. With RSI at 65.2 the momentum picture is approaching overbought, alongside a bullish MACD signal. Recent trading has carved out support near $167.50 and resistance around $196.63.
Valuation screens as fair, on a P/E of 11.2 with no clean sector comparison available. Revenue is growing at 36.2% on a 6.8% profit margin.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 42.2%, a beta of 0.07 and a maximum drawdown of 20.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on buy — conviction 5 out of 10.

Top Market Events

FAIRPORT, N.Y., Aug. 06, 2026 GLOBE NEWSWIRE -- Seneca Foods Corporation NASDAQ: SENEA, SENEB today announced financial...FAIRPORT, N.Y., Aug. 06, 2026 GLOBE NEWSWIRE -- Seneca Foods Corporation NASDAQ: SENEA, SENEB today announced financial...FAIRPORT, N.Y., Aug. 06, 2026 GLOBE NEWSWIRE -- Seneca Foods Corporation NASDAQ: SENEA, SENEB today announced financial...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 141.83
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 141.83
  • 30-day volatility of 42.2%

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Revenue growth of +36.2%
  • P/E ratio of 11.2
  • Return on equity of 16.8%

Key Metrics & Analysis

Financial Health

Revenue Growth36.20%
Profit Margin6.75%
P/E Ratio11.2
ROE16.82%
ROA8.28%
Debt/Equity31.02
P/B Ratio1.7
Op. Cash Flow$279.9M
Free Cash Flow$138.2M

Technical Analysis

TrendBullish
RSI65.2
Support$167.50
Resistance$196.63
MA 20$184.83
MA 50$174.38
MA 200$141.83
MACDBullish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$686.13
GradeFair
TypeBlend

Risk Assessment

Beta0.07
Volatility42.15%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.